Atrys Health (Spain) Top Management
ATRY Stock | EUR 3.14 0.11 3.38% |
Atrys Health employs about 2.4 K people. The company is managed by 14 executives with a total tenure of roughly 48 years, averaging almost 3.0 years of service per executive, having 171.21 employees per reported executive. Evaluation of Atrys Health's management performance can provide insight into the firm performance.
Isabel Fernandez CEO Chief Executive Officer |
Santiago Sanahuja Chairman Executive Chairman of the Board |
Atrys |
Atrys Health Management Team Effectiveness
Atrys Health's management efficiency ratios could be used to measure how well Atrys Health manages its routine affairs as well as how well it operates its assets and liabilities.Atrys Health Workforce Comparison
Atrys Health SL is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 14,559. Atrys Health retains roughly 2,397 in number of employees claiming about 16% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of (0.13) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01. Atrys Health SL Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Atrys Health SL Price Series Summation is a cross summation of Atrys Health price series and its benchmark/peer.
Atrys Health Notable Stakeholders
An Atrys Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Atrys Health often face trade-offs trying to please all of them. Atrys Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Atrys Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Isabel Fernandez | Chief Executive Officer | Profile | |
Santiago Sanahuja | Executive Chairman of the Board | Profile | |
Carlos CordonCardo | Scientific Vice President | Profile | |
Carlo Greco | Vice President of Medical Radiotherapy | Profile | |
Jose Ginesta | Chief Financial Officer | Profile | |
Anna Valero | Diagnostics Director | Profile | |
Victor Rumayor | R&D Director | Profile | |
Eduardo Dussel | Director of Teleradiology | Profile | |
Helena VidalFolch | Head Communication | Profile | |
Gabriela Camunas | G Counsel | Profile | |
Encarna Vega | Adm Director | Profile | |
Maria Marin | Head Relations | Profile | |
Zvi Fuchs | Founder VP | Profile | |
Carlos Girn | Chief Officer | Profile |
About Atrys Health Management Performance
The success or failure of an entity such as Atrys Health SL often depends on how effective the management is. Atrys Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Atrys management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Atrys management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 525 people.
Please note, the presentation of Atrys Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Atrys Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Atrys Health's management manipulating its earnings.
Atrys Health Workforce Analysis
Traditionally, organizations such as Atrys Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Atrys Health within its industry.Atrys Health Manpower Efficiency
Return on Atrys Health Manpower
Revenue Per Employee | 50.5K | |
Revenue Per Executive | 8.6M | |
Net Loss Per Employee | 9.7K | |
Net Loss Per Executive | 1.7M |
Complementary Tools for Atrys Stock analysis
When running Atrys Health's price analysis, check to measure Atrys Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atrys Health is operating at the current time. Most of Atrys Health's value examination focuses on studying past and present price action to predict the probability of Atrys Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atrys Health's price. Additionally, you may evaluate how the addition of Atrys Health to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |